Mizuho Securities Upgrades The Medicines Company (MDCO) to Buy Following Negative Verdict; Overhang Removed
Tweet Send to a Friend
Mizuho Securities upgraded The Medicines Company (NASDAQ: MDCO) from Neutral to Buy with a price target of $41.00 (from $27.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
